新加坡HSA召回Farganesse Injection 50mg/2ml(异丙嗪)4个批次,因安瓿中出现颗粒物
Recall of Farganesse Injection 50mg/2ml (promethazine)
新加坡HSA于2026年11月12日召回Farganesse Injection 50mg/2ml(异丙嗪),问题为安瓿中存在颗粒物。召回级别为1级,范围为零售环节,涉及批次0015318、0015319、0015320、0015321,本地公司为FarmaMondo Pte. Ltd.与Pharm-D (Singapore) Pte. Ltd.。
材料给出1级召回涉及的四个批次与零售环节停用、退库要求,可对照手头库存批号核实是否在范围内。
Date of recall: | 12 November 2026 |
Product: | Farganesse Injection 50mg/2ml |
Active Ingredient: | Promethazine |
Product Category: | Therapeutic Product |
Batch No.: | 0015318, 0015319, 0015320, 0015321 |
Class of Recall: | 1 |
Level of Recall: | Retail |
Local Company: | FarmaMondo Pte. Ltd. Pharm-D (Singapore) Pte. Ltd. |
Description of Issue: | Presence of particles in ampoules. |
Recall Instructions: | Hospitals, clinics, pharmacies: Stop supplying the affected batch and return the remaining stocks to the company. |
来源:HSA 治疗药品召回 · hsa.gov.sg